Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Summary

The purpose of this study is to evaluate the efficacy and safety of recombinant anti-tumor and anti-virus protein for injection in treating patients with metastatic colorectal cancer after failure of second-line and more than second-line treatment.

Timeline

Start

2011-05

Primary completion

2013-05

Completion

2014-05

Publications

• Jia R, Wang Y, Mao XY, Li SS, Xu N, Xiong JP, Shen L, Bai L, Liu W, Liu LJ, Ge FJ, Chen YL, Lin L, Xu JM. Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment. Oncologist. 2015 Jun;20(6):619-20. doi: 10.1634/theoncologist.2014-0439. Epub 2015 Apr 29.

Drugs

Indications